期刊名称：THERAPEUTIC ADVANCES IN GASTROENTEROLOGY ISSN： 1756-283X 出版频率： Continuous publication 出版社： SAGE PUBLICATIONS LTD, 1 OLIVERS YARD, 55 CITY ROAD, LONDON, ENGLAND, EC1Y 1SP   出版社网址： http://www.uk.sagepub.com/home.nav 期刊网址： http://www.uk.sagepub.com/journalsProdDesc.nav?prodId=Journal201897&ct_p=title&crossRegion=asia 影响因子： 4.409 主题范畴： GASTROENTEROLOGY & HEPATOLOGY 变更情况： 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal Therapeutic Advances in Gastroenterology Frequency: Published 6 times a year eISSN: 1756-2848 ISSN: 1756-283X Months of Distribution: January , March , May , July , September , November 2013 Unofficial Impact Factor: 2.169 Source: Based on data from Thomson Reuters Web of KnowledgeSM Therapeutic Advances in Gastroenterology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of gastroenterology. You can access the journal online for free at www.sagepub.com/tag. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in gastroenterology and hepatology, providing a forum in print and online for publishing the highest quality articles in this area. The editors welcome articles of current interest on research across all areas of gastroenterology, including Helicobacter pylori; upper-gastrointestinal disease; functional gastrointestinal disorders; inflammatory bowel disease; therapeutic advances in cancer; colorectal-cancer screening, celiac disease, liver disorders and transplantation, biliary tract disorder, pancreatitis, gastrointestinal bleeding, diarrheal disease, nutrition, advances in diagnostic and therapeutic endoscopy, and any other relevant topic in the field. It publishes expert opinion reviews (including single-drug and drug class reviews), narrative reviews and analysis of published guidelines (as editorials or reviews). Original research manuscripts of well-designed trials are also welcomed that show drug or drug class efficacy in a particular disease or therapeutic area. The journal strongly encourages the submission of original research with positive or negative results. The journal adheres to a blind review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees - a first editorial decision is generally reached within 3 weeks of submission. Online publication of articles occurs within 7 weeks from acceptance. Further information for contributors is provided on the back pages of each issue and online. For all commercial sales and sponsorship enquiries, including advertising, reprints and supplements, please contact: Commercial Sales Team, London, UK Tel. +44 20 7336 1205 Email: reprints@sagepub.co.uk This journal is a member of the Committee on Publication Ethics (COPE). Aims & Scope Therapeutic Advances in Gastroenterology is aimed at clinicians and researchers in gastroenterology and will be a forum for all views and reviews relating to this discipline. Topics covered will include: Helicobacter pylori; peptic ulcer disease; non-ulcer dyspepsia; gastric cancer; gastroesophageal reflux disease; Barrett's esophagus; esophageal motility disorders; esophageal cancer; inflammatory bowel disease (complication of disease, extraintestinal cancer, lymphoma, gender issues, safety of medical therapy, Crohn's disease, ulcerative colitis, indeterminate colitis); pancreatitis and pancreatic cancer; gastrointestinal bleeding; NOTES (natural orifice transluminal endoscopic surgery); colorectal cancer screening; celiac disease; diarrheal diseases; chronic HBV and HCV and models of infection; nonalcoholic fatty liver disease; alcoholic liver disease; autoimmune hepatitis; primary biliary cirrhosis; primary sclerosing cholangitis; hepatocellular carcinoma; noninvasive markers of fibrosis and antifibrotic therapy; functional imaging of the liver; genomics of liver disease; high-throughput approaches to target discovery in HCV; liver transplantation; vascular disorders of the liver. The journal operates a conventional single-blind reviewing policy in which the reviewer's name is always concealed from the submitting author. In general, Editors will seek advice from two or more expert reviewers about the scientific content and presentation of submitted articles. 1. The purpose of the Journal is to publish (in the English language) articles, reviews and scholarly comment which have been judged worthy of publication by appropriate specialists and accepted by the Editor on studies relating to gastroenterological disease, pharmacology and medicine. The Journal is for all professionals concerned with hepatology and gastroenterology and is a forum for all views on related subjects. The editorial board welcomes articles of current interest on original research, reviews and clinical studies. 2. The Journal will be international in the sense that it will seek, wherever possible, to publish material from authors with an international reputation and articles that are of interest to an international audience. 3. In pursuit of the above the journal shall: (i) draw on and include high quality work from the international community of scholars including those in the major countries of Europe, Australasia, the United States, other parts of the Americas, countries in the Third World and elsewhere with due representation for considerations of the readership. The Journal shall include work representing the major areas of interest in contemporary research in gastroenterology. (ii) avoid bias in favour of the interests of particular schools or directions of research or particular political or narrow disciplinary objectives to the exclusion of others; (iii) ensure that articles are written in a terminology and style which makes them intelligible, not merely within the context of a particular discipline or abstract mode, but across the domain of relevant disciplines. Abstracting/Indexing Chemical Abstracts Service (CAS)  Medscape  PubMed  Scopus   Instructions to Authors Manuscript Submission Permissions  |   Foreign Rights  |   Reprints and Sponsorship  |   Advertising     Correspondence and online submission Publication categories Writing your manuscript  Reference style 4.1 Corresponding author contact details Research ethics Publication statement Peer review statement Journal contributor’s publishing agreement Declaration of conflicting interests policy Authorship Funding Acknowledgement Informed consent Permissions After acceptance 10.1 Proofs 10.2 E-Prints and complimentary copies 10.3 SAGE production 10.4 OnlineFirst publication 10.5 SAGE Choice Editorial Board Editor-in-Chief: Timothy Cragin Wang Columbia University Medical Center, New York, NY, USA Editor: Alessandro Baliani SAGE Publications Ltd, London, UK Associate Editors: Nadir Arber Tel Aviv Medical Centre, Israel Robert Benamouzig Avicenne Hospital, Paris-13 University, Bobigny, France Ray Chung Massachusetts General Hospital, Boston, MA, USA Gary Lichtenstein Hospital of the University of Pennsylvania, Philadelphia, PA, USA Peter J Whorwell Wythenshawe Hospital, Manchester, UK   Editorial Board: Julian A. Abrams Columbia University College of Physicians & Surgeons, New York, NY, USA John Atherton Queen's Medical Centre, Nottingham, UK Bruce Bacon Saint Louis University, St Louis, MO, USA Massimo Campieri University of Bologna, Bologna, Italy John Carethers University of California, San Diego, USA Lin Chang UCLA Division of Digestive Diseases, Los Angeles, CA, USA Tsutomu Chiba Graduate School of Medicine, Kyoto University, Japan Dan Chung Massachusetts General Hospital, Boston, MA, USA Andy Dannenberg Weill Cornell Medical College, New York, USA Subrata Ghosh University of Calgary, Canada Peter Green Columbia University College of Physicians and Surgeons, New York, NY, USA Stephen Harrison Brooke Army Medical Center, San Antonio, TX, USA Toshifumi Hibi Keio University School of Medicine, Tokyo, Japan John M Inadomi University of Washington, Seattle, WA, USA Donald M Jensen University of Chicago Medical Center, Chicago, IL, USA Derek Jewell University of Oxford, Oxford, UK Brad Kuo Massachusetts General Hospital, Boston, MA, USA Daryl Lau Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA Georg Lauer Massachusetts General Hospital, Boston, MA, USA Jaw-Town Lin National Taiwan University Hospital, Taipei, Taiwan Uma Mahadevan-Velayos University of California, San Francisco, CA, USA Peter Malfertheiner Otto-von-Guericke-Universitet, Magdeburg, Germany John McLaughlin Manchester University, Manchester, UK David Nelson University of Florida, Jacksonville, FL, USA Jean-Michel Pawlotsky Henri Mondor Hospital, University of Paris, Criteil, France Richard M. Peek Jr Vanderbilt University Medical Center, Vanderbilt, TN, USA Daniel Pratt Massachusetts General Hospital, Boston, MA, USA David Mark Pritchard Liverpool University, Liverpool, UK Daniel Rachmilewitz Shaare Zedek Medical Center, Jerusalem, Israel Raj Reddy University of Pennsylvania, Philadelphia, PA, USA Ken Sherman University of Cincinnati, Cincinnati, OH, USA Mitch Shiffman VCU Medical Center, Richmond, Virginia, USA Kentaro Sugano Jichi Medical University, Tochigi-ken, Japan Mark Sulkowski Johns Hopkins University School of Medicine, Baltimore, MD, USA Doug Taupin The Canberra Hospital, Canberra, ACT, Australia Andrea Todisco University of Michigan, Ann Arbor, MI, USA Thomas Ullman Mount Sinai Medical Center, New York, NY, USA Saif M. Wasif Tufts Medical Center and Tufts Cancer Center, Boston, MA, USA Heiner Wedemeyer Hannover Medical School, Germany Bertram Wiedenman University Medicine Berlin, Berlin, Germany Benjamin Wong University of Hong Kong, Hong Kong, PRC Deng-Chyang Wu Kaohsiung Medical University Hospital, Hong Kong, PRC Neville Yeomans University of Western Sydney, Sydney, NSW, Australia